1 completed, 1 recruiting, 1 terminated, 1 unknown. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Primary Graft Dysfunction: new trials by email Literature Review of Primary Graft Dysfunction trials Research Report on Primary Graft Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction Maraviroc, Placebo - Primary Graft Dysfunction, Lung Transplantation | Phase 2 | Recruiting | University of California, San Francisco | 120 | 2025-12-07 | 2026-01-20 |
| Perioperative Vitamin C Lung Transplant Vitamin C - Primary Graft Dysfunction, Lung Transplant; Complications | Phase 2 | Withdrawn | University of Wisconsin, Madison | 2023-04-01 | 2023-05-01 | |
| Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction Sodium Nitrite - Primary Graft Dysfunction | Phase 2 | Terminated | Gladwin, Mark, MD | 3 | 2011-10-01 | 2018-08-01 |
| Use of N-Acetylcysteine During Liver Procurement N-acetylcystein - Liver Failure, Liver Failure, Acute | Phase 2 | Completed | Azienda Ospedaliera di Padova | 140 | 2006-12-01 | 2013-02-18 |
| The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study Surfactant (calfactant) - Lung Transplantation, Primary Graft Dysfunction | Phase 2 / Phase 3 | Unknown | Rabin Medical Center | 42 | 2005-01-01 | 2007-07-25 |
Acute Lung Injury (1) · Carcinoma, Hepatocellular (1) · Liver Diseases (1) · Liver Failure (1) · Liver Failure, Acute (1) · Liver Neoplasms (1)
Cardiovascular Diseases (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Postoperative Complications (5) · Reperfusion Injury (5) · Vascular Diseases (5) · Adenocarcinoma (1) · Carcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Hepatic Insufficiency (1) · Lung Diseases (1) · Lung Injury (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Acetylcysteine (1) · Ascorbic Acid (1) · Maraviroc (1) · N-monoacetylcystine (1) · Sodium Nitrite (1) · Surface-Active Agents (1) · calfactant (1) · halofantrine (1)
Azienda Ospedaliera di Padova (1) · Gladwin, Mark, MD (1) · Rabin Medical Center (1) · University of California, San Francisco (1) · University of Wisconsin, Madison (1)
United States (2) · Israel (1) · Italy (1)
Daniel Calabrese, MD (1) · Francesco D'Amico, MD (1) · Matthew Morrell, MD (1) · Micah Long, MD (1) · MordechaI R Kramer, Prof (1) · Umberto Cillo, MD (1)